Template:Carteolol: Difference between revisions

Latest revision as of 17:58, 4 February 2014

Carteolol
OCUPRESS^® FDA Package Insert
Indications and Usage
Dosage and Administration
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
How Supplied/Storage and Handling
Patient Counseling Information
Clinical Trials on Carteolol
ClinicalTrials.gov

@@ Line 7: / Line 7: @@
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Carteolol dosage and administration|Dosage and Administration]]
-|-
-! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Carteolol dosage forms and strengths|Dosage Forms and Strengths]]
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Carteolol contraindications|Contraindications]]
@@ Line 27: / Line 25: @@
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Carteolol nonclinical toxicology|Nonclinical Toxicology]]
-|-
-! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Carteolol clinical studies|Clinical Studies]]
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Carteolol how supplied storage and handling|How Supplied/Storage and Handling]]
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Carteolol patient counseling information|Patient Counseling Information]]
-|-
-! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Carteolol labels and packages|Labels and Packages]]
 |-
 ! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Clinical Trials on Carteolol